@lipidjournal.bsky.social#JCLSpotlight from the 2026 ACC/AHA/Multisociety Dyslipidemia Guideline Special Issue: "Imaging guided treatment of subclinical atherosclerosis—We’ve come a long way!"
Read now: https://ow.ly/QXqq50ZXAjA
Read the entire issue: https://ow.ly/XyJF50ZXAjE
@lipidjournal.bsky.socialHappy #FHAwarenessDay!
What will it take to close the FH care gap? This #JCLSpotlight for #CholesterolMonth says it's multiple strategies working together, not just one fix. #KnowFH
Read more:
https://ow.ly/RqYQ50ZQMya
@lipidjournal.bsky.social#FHAwarenessDay is 1 day away!
This #JCLSpotlight for #CholesterolMonth explores how a structured transition model can help bridge the gap for young FH patients moving from pediatric to adult care. #KnowFH
@lipidjournal.bsky.social2 days until #FHAwarenessDay!
Our #JCLSpotlight for #CholesterolMonth highlights how correcting LDL-C for Lp(a) improves FH diagnosis and reduces false positives. #KnowFH
Read more:
https://ow.ly/zAN150ZQ9XA
@lipidjournal.bsky.social#JCLSpotlight for #CholesterolMonth: Are lipid-lowering drugs safe during pregnancy? This Czech nationwide study offers new insight into maternal and fetal outcomes.
Read more:
https://ow.ly/bp4P50ZNRqo
@lipidjournal.bsky.social#JCLSpotlight for #CholesterolMonth: New research finds Lp(a) plasma levels have no major effect on coagulation phenotype, though high levels were associated with a mild increase in FV:C.
